However, a previous study found no differences in circulating levels of bradykinin and kallidin peptides, and low molecular weight kininogens, or in plasma kallikrein or kallistatin although plasma TK levels were higher in subjects with type 2 diabetes. The gene discussed is KNG1; the disease is type 2 diabetes mellitus.